SEC
SlamSEC
SearchBrowseEarnings

BIOLIFE SOLUTIONS INC

Nasdaq:BLFS
Electromedical & Electrotherapeutic Apparatus·BOTHELL, WA
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

Summary Financials

CFO
Wichterman Troy
Revenue
$8.9M
+58.0% YoY
FY 2014
Adj. EBITDA
-$10.1M
-112.8% margin
FY 2025
Net Income
-$68.0M
-759.8% margin
FY 2025
EPS (Diluted)
-$1.55
FY 2025
Stock Price
$19.01
+1.8%
2026-03-11
52W Range
$18.29 – $29.62
P/E Ratio
-12.3x
Market Cap
$918.2M
Cash
$91.5M
FY 2025
Total Debt
$5.0M
FY 2025
Net Cash
$86.5M
FY 2025
Enterprise Value
$831.6M
Debt / EBITDA
8.6x
FY 2014
EV / EBITDA
-82.4x
Employees
—